Generic Versus Branded Enoxaparin in Prophylaxis and Treatment of Vein Thrombosis

Revista da Associacao Medica Brasileira- Brazil

doi 10.1590/1806-9282.61.01.044

Full Text

Abstract

Available in

Categories

Medicine

Date

Authors

Publisher

FapUNIFESP (SciELO)

Related search

Treatment of Deep Vein Thrombosis With Enoxaparin in Pediatric Cancer Patients Receiving Chemotherapy.

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Treatment of Deep Vein Thrombosis With Enoxaparin in Pediatric Cancer Patients Receiving Chemotherapy

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2007English

Ximelagatran for Treatment and Prophylaxis of Recurrent Events in Deep Vein Thrombosis

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2007English

Branded Versus Generic Drug Use in Chronic Disease Management in Hong Kong

Hong Kong Medical Journal
Medicine
2019English

Improving Deep Vein Thrombosis Prophylaxis With Mechanical Modalities in Surgical Intensive Care Unit

Journal of Nursing Care Quality
Nursing
2015English

Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis Versus Proximal Deep-Vein Thrombosis: Findings From XALIA

TH Open
2019English

Deep Vein Thrombosis in Severe Motor and Intellectual Disabilities Patients and Its Treatment by Anticoagulants of Warfarin Versus Edoxaban

Annals of Vascular Diseases
2019English

Upper Extremity Deep Vein Thrombosis: Clinical and Treatment Characteristics

Journal of International Medical Research
BiochemistryMedicineCell Biology
2004English

Subcutaneous or Intravenous Heparin in Treatment of Deep Vein Thrombosis

BMJ
1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy